Download video

How might itacitinib prophylaxis impact haplo-HSCT outcomes in the future?

100 views

GvHD Hub

2 years ago

How might itacitinib prophylaxis impact haplo-HSCT outcomes in the future?

How might itacitinib prophylaxis impact haplo-HSCT outcomes in the future?

How might itacitinib prophylaxis impact haplo-HSCT outcomes in the future?
7:50
How might itacitinib prophylaxis impact haplo-HSCT outcomes in the future?
by GvHD Hub
Itacitinib and corticosteroids for chronic GvHD
7:37
Itacitinib and corticosteroids for chronic GvHD
by GvHD Hub
The Future of Cardiology: Groundbreaking Trials, Therapies, and Innovations in Cardiovascular Care 🌟
13:44
The Future of Cardiology: Groundbreaking Trials, Therapies, and Innovations in Cardiovascular Care 🌟
by Apex Heart and Vascular
Effective treatment of low risk acute GVHD with itacitinib monotherapy
2:29
Effective treatment of low risk acute GVHD with itacitinib monotherapy
by ecancer
Use of belimumab for prophylaxis of chronic GvHD
5:47
Use of belimumab for prophylaxis of chronic GvHD
by VJHemOnc – Video Journal of Hematology \& HemOnc
How do pre-allo-HSCT conditioning regimens impact GvHD outcomes in myelofibrosis patients?
5:38
How do pre-allo-HSCT conditioning regimens impact GvHD outcomes in myelofibrosis patients?
by GvHD Hub
How does GvHD affect outcomes for pediatric patients undergoing allo-SCT for ALL?
2:21
How does GvHD affect outcomes for pediatric patients undergoing allo-SCT for ALL?
by GvHD Hub
How can patient-reported QoL change our view on unmet needs in GvHD?
16:57
How can patient-reported QoL change our view on unmet needs in GvHD?
by GvHD Hub
Itacitinib in patients with acute GvHD
3:55
Itacitinib in patients with acute GvHD
by VJHemOnc – Video Journal of Hematology \& HemOnc
Updated safety \& efficacy data from MANIFEST-2: pelabresib plus ruxolitinib for myelofibrosis
4:35
Updated safety \& efficacy data from MANIFEST-2: pelabresib plus ruxolitinib for myelofibrosis
by VJHemOnc – Video Journal of Hematology \& HemOnc
🔴Physiological Idea behind Management of Shock🫀
8:52
🔴Physiological Idea behind Management of Shock🫀
by Surgical Critical Care 🏡 Dr. Mohamed Hegazy
Decoding PI: Unraveling the GI connection
1:16:06
Decoding PI: Unraveling the GI connection
by Immune Deficiency Foundation
Belimumab for the prophylaxis of chronic GvHD
2:26
Belimumab for the prophylaxis of chronic GvHD
by VJHemOnc – Video Journal of Hematology \& HemOnc
Clinical Trials of Itacitinib for Chronic and Acute GVHD
2:55
Clinical Trials of Itacitinib for Chronic and Acute GVHD
by OncLive
Itacitinib Clinical Trials for Chronic and Acute GVHD
3:12
Itacitinib Clinical Trials for Chronic and Acute GVHD
by OncLive
FAQ: Describe the IL23\/IL17 axis
2:02
FAQ: Describe the IL23\/IL17 axis
by GHAPP Digital
Procalcitonin Guideline for ED
10:23
Procalcitonin Guideline for ED
by EM Note
\\
28:46
\\"🌟 Histotripsy and Hepzato: The Future of Liver Cancer Treatment 🩺\\"
by A Cure In Sight
How can mRNA be used to develop new therapies? - Dr Seth Cheetham explains
1:48
How can mRNA be used to develop new therapies? - Dr Seth Cheetham explains
by AIBNatUQ
What is the latest update on biomarkers for assessing GvHD?
6:16
What is the latest update on biomarkers for assessing GvHD?
by GvHD Hub
Say Goodbye to Dialysis! How CKD Patients Are Restoring Their GFR Naturally
23:49
Say Goodbye to Dialysis! How CKD Patients Are Restoring Their GFR Naturally
by NutriSite
Repurposing drugs for the treatment of acute GvHD
1:20
Repurposing drugs for the treatment of acute GvHD
by VJHemOnc – Video Journal of Hematology \& HemOnc
Biomarkers for Graft-Versus-Host Disease: What Is a Biomarker?
2:16
Biomarkers for Graft-Versus-Host Disease: What Is a Biomarker?
by Managed Healthcare Executive